Do ARKG and GNMX hold the same stocks?

By their latest filings, 32% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.

Which is more different from the S&P 500, ARKG or GNMX?

ARKG has 5% of its weight in S&P 500 names and GNMX has 31%, so GNMX differs more from the index.

Which is cheaper, ARKG or GNMX?

ARKG charges 0.75% a year and GNMX charges 0.35%, so GNMX is cheaper. Fees come from each fund's prospectus.

Data as of Nov 4, 2026.

Thematic ETFs

ARKG vs GNMX: Holdings Overlap & Returns

Share on X Download as PDF

ARKG and GNMX hold 32% of their weight in the same names.

askIQ about this page

askIQ about ARKG and GNMX

Net assets: $2.1bn on Nov 2, 2026 for ARK Genomic Revolution ETF, and $1.3m on Nov 4, 2026 for Corgi Genomics & Precision Medicine ETF.

ARKG on its own →GNMX on its own →

At a glance

4.6%

ARKG in the S&P 500

31.0%

GNMX in the S&P 500

+68.4%

ARKG total return, 1 year

+48.3%

GNMX total return, 6 months

ARKG · 1 year to Nov 4, 2026 95% of its weight is outside the S&P 500

5% of ARKG's weight is in S&P 500 companies and 95% is outside the index. Holdings as of Nov 2, 2026.

GNMX · 6 months to Nov 4, 2026 69% of its weight is outside the S&P 500

31% of GNMX's weight is in S&P 500 companies and 69% is outside the index. Holdings as of Nov 4, 2026.

Pair scorecard

GNMX costs 0.40 points a year less; ARKG is far larger, $2.1bn against $1.3m.

ARKG vs GNMX: Holdings Overlap & Returns
Measure	ARKG	GNMX
Return
Measure	ARKG	GNMX
Total return, 1 year	+68.4%	not published
Drawdown
Measure	ARKG	GNMX
Below its all-time high	55.5%, high on Jan 20, 2021
Benchmark
Measure	ARKG	GNMX
What it tracks	Genomics and gene editing	Genomics and gene editing
Cost and size
Measure	ARKG	GNMX
Expense ratio	0.75%	0.35%
Net assets, as of Nov 2, 2026	$2.1bn	$1.3m
Active share vs the S&P 500	98%	99%
Holdings
Measure	ARKG	GNMX
Holdings in common	32%
Top ten holdings, share of the fund	58%	49%

Method

Risk and return

May 15, 2026 to Oct 30, 2026 · 24 weekly returns

ARKG GNMX

Return

Total return edge ARKG +82.6% +56.8%

Price return edge ARKG +82.6% +56.8%

Risk

Max drawdown edge GNMX −13.5% −7.3%

Reading

From May 2026 to Oct 2026, ARKG returned more: +82.6% to +56.8%. GNMX fell less at its worst: −7.3% to −13.5%.

Full scorecard

3 measures, with how each is measured Open ↓

Risk and return: ARKG vs GNMX: Holdings Overlap & Returns
Measure	ARKG	GNMX	Edge	How it is measured
Return
Total return	+82.6%	+56.8%	ARKG	Price change plus distributions, reinvested.
Price return	+82.6%	+56.8%	ARKG	Price change alone, distributions left out.
Risk
Max drawdown	−13.5%	−7.3%	GNMX	Deepest fall from a high to the low after it.

Computed by ETFIQ from Tiingo daily prices and ETFIQ's distribution records, 24 weekly returns. Cash rate: the 13-week Treasury bill.

What they share

32%

By the books each fund has filed, ARKG and GNMX hold 32% of their money in the same securities at the same weight. Holdings dated Nov 2, 2026 and Nov 4, 2026.

50%

0 half 100%

half

32% in common

Positions both hold · largest shared weight first ARKG GNMX

ILLUMINA INC 4.26% 3.92%

GUARDANT HEALTH INC 5.13% 3.45%

10X GENOMICS INC-CLASS A 7.52% 2.87%

CAREDX INC 4.50% 2.43%

TWIST BIOSCIENCE CORP 7.42% 2.32%

TEMPUS AI INC-CL A 9.85% 1.86%

ADAPTIVE BIOTECHNOLOGIES 2.28% 1.65%

VERACYTE INC 3.80% 1.46%

SCHRODINGER INC 2.93% 1.36%

CRISPR THERAPEUTICS AG 5.48% 1.28%

ABSCI CORP 5.08% 1.19%

IONIS PHARMACEUTICALS INC 1.79% 1.01%

Only in one fund ↓

Only in ARKG

NATERA INC 4.67%

ELI LILLY & CO 4.59%

COMPASS PATHWAYS PLC 2.05%

ALAMAR BIOSCIENCES INC 1.61%

BUTTERFLY NETWORK INC 1.50%

908 DEVICES INC 1.00%

FREENOME INC 0.99%

SCRIBE THERAPEUTICS INC 0.98%

Only in GNMX

Moderna Inc 11.24%

Thermo Fisher Scientific Inc 8.88%

Vertex Pharmaceuticals Inc 6.04%

Genmab A/S 4.39%

Revolution Medicines Inc 3.24%

Incyte Corp 2.70%

GRAIL Inc 2.26%

Bio-Techne Corp 2.10%

Check overlap with more funds →

Window by window

Window by window: ARKG vs GNMX: Holdings Overlap & Returns
	Total return
Window	ARKG	GNMX
3 months	+20.5%	+24.3%
6 months	+60.0%	+48.3%
1 year	+68.4%	–
3 years	+90.8%	–
Since launchNot the same days: ARKG Oct 2014 · GNMX May 2026	+164.2%	+48.3%

– means no data for this window. Open this comparison in the app →

Side by side

ARKG ARK Genomic Revolution ETF · Holds 35 stocks in genomics and gene editing, 5% of its weight in S&P 500 companies GNMX Corgi Genomics & Precision Medicine ETF · Holds 57 stocks in genomics and gene editing, 31% of its weight in S&P 500 companies

Issuer ARK Corgi

Theme Genomics and gene editing Genomics and gene editing

In the S&P 500 4.6% 31.0%

Active share vs the S&P 500 98.5% 99.4%

In the Nasdaq-100 0.0% 7.7%

Holdings 35 57

Top ten, share of the fund 58.5% 49.2%

Expense ratio 0.75% 0.35%

Fee for the differing part 0.76% 0.35%

Total return, 1 year +68.4% +48.3% (since launch, May 6, 2026)

vs its benchmark not measured not measured

Below its high −55.5% −4.2%

Net assets, ARKG as of Nov 2, 2026 and GNMX as of Nov 4, 2026 $2.1bn $1.3m

As of Nov 4, 2026. Source: ETFIQ.

32% of the two portfolios are the same securities at the same weight.

Client brief

No client brief for this pair: ETFIQ prints no one-year total return for GNMX.

Alert

About each fund

ARKG

By weight, 5% of ARKG's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 58% of the fund across 35 positions, as published by its issuer for Nov 2, 2026. Over the year to Nov 4, 2026 the fund returned +68.4% with distributions reinvested. It sits 55.5% below its all-time high of Jan 20, 2021.

GNMX

By weight, 31% of GNMX's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 49% of the fund across 57 positions, as published by its issuer for Nov 4, 2026. Since it first traded on May 6, 2026 the fund returned +48.3% with distributions reinvested.

Questions people ask

Do ARKG and GNMX hold the same stocks?: By their latest filings, 32% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.
Which is more different from the S&P 500, ARKG or GNMX?: ARKG has 5% of its weight in S&P 500 names and GNMX has 31%, so GNMX differs more from the index.
Which is cheaper, ARKG or GNMX?: ARKG charges 0.75% a year and GNMX charges 0.35%, so GNMX is cheaper. Fees come from each fund's prospectus.

Other comparisons

ARKG vs GNOM ARKG vs IDNA ARKG vs NLR ARKG vs ARTY GNMX vs IDNA GNMX vs GNOM GNMX vs PBPH GNMX vs PBE

Where to next

All thematic ETFs ranked by the S&P 500 Difference Score →How the scores are computed →ARKG on its own →GNMX on its own →ARKG holdings →GNMX holdings →Method →Standards and sources →

Sources and dates

ARKG filings on SEC EDGAR ↗

ARKG prospectus with the expense ratio (SEC) ↗

ARK page for ARKG ↗

GNMX filings on SEC EDGAR ↗

GNMX prospectus with the expense ratio (SEC) ↗

Corgi website ↗

Links are sources, not endorsements. A comparison is not a recommendation.

How this is computed

Overlap adds up the smaller of the two weights for each security both funds hold.

Every number is an ETFIQ calculation with distributions reinvested.

Cite this pageCitation, APA and Markdown

ETFIQ, ARKG against GNMX, data as of Nov 4, 2026. https://etfiq.com/compare/themes/arkg-vs-gnmx

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.